in Singapore conducted a phase 1 study to assess the safety and the pharmacokinetic profile of retatrutide [35]
In my private practice, I started using GLP-1 drugs such as exenatide in 2006 and liraglutide in 2010 for my patients with type 2 diabetes
Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines
Furthermore, retatrutide showed the largest decreases in food intake, and chronic treatment for 10 days attenuated the described effects
MYTH: GLP1 Drugs Are the Easy Way Out
While GLP-1 RAs may cause some side effects, most commonly diarrhea, vomiting, and nausea, these range from mild to moderate and can be lessened by reducing the dose